These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10340106)

  • 21. Interpreting radiographic data in rheumatoid arthritis.
    Ory PA
    Ann Rheum Dis; 2003 Jul; 62(7):597-604. PubMed ID: 12810418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
    Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of anti-TNF therapy in rheumatoid arthritis].
    Meyer O
    Presse Med; 2000 Mar; 29(9):463-8. PubMed ID: 10745935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of tumor necrosis factor for rheumatoid arthritis.
    Moreland LW
    J Rheumatol Suppl; 1999 May; 57():7-15. PubMed ID: 10328137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis.
    De Filippis L; Caliri A; Anghelone S; Scibilia G; Lo Gullo R; Bagnato G
    Panminerva Med; 2006 Jun; 48(2):129-35. PubMed ID: 16953150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psoriatic arthritis.
    Goupille P
    Joint Bone Spine; 2005 Dec; 72(6):466-70. PubMed ID: 16310398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel therapies for ankylosing spondylitis.
    Maksymowych WP
    Curr Rheumatol Rep; 2005 Jun; 7(3):182-7. PubMed ID: 15918993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. USAN Council. List No.407. New names. Lenercept.
    Clin Pharmacol Ther; 1998 Aug; 64(2):234. PubMed ID: 9758530
    [No Abstract]   [Full Text] [Related]  

  • 29. Which TNF inhibitor for rheumatoid arthritis?
    Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
    [No Abstract]   [Full Text] [Related]  

  • 30. Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy.
    Gómez-Puerta JA; Sanmartí R; Rodríguez-Cros JR; Cañete JD
    Ann Rheum Dis; 2004 Jul; 63(7):896. PubMed ID: 15194598
    [No Abstract]   [Full Text] [Related]  

  • 31. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders.
    Calamia KT
    Adv Exp Med Biol; 2003; 528():545-9. PubMed ID: 12918761
    [No Abstract]   [Full Text] [Related]  

  • 32. Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al.
    Neovius M; Askling J
    Ann Rheum Dis; 2014 Jun; 73(6):e32. PubMed ID: 24638970
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
    Koike R; Takeuchi T; Eguchi K; Miyasaka N;
    Mod Rheumatol; 2007; 17(6):451-8. PubMed ID: 18084695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF blocker drugs used to fight inflammation go head-to-head. Adalimumab had highest treatment response and remission rates, etanercept has longest drug survival rates; infliximab placed third.
    Duke Med Health News; 2010 Mar; 16(3):3. PubMed ID: 20461880
    [No Abstract]   [Full Text] [Related]  

  • 36. Overview of radiologic efficacy of new treatments.
    van der Heijde DM
    Rheum Dis Clin North Am; 2004 May; 30(2):285-93, vi. PubMed ID: 15172041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of tumor necrosis factor: new treatment options for rheumatoid arthritis.
    Moreland LW
    Cleve Clin J Med; 1999 Jun; 66(6):367-74. PubMed ID: 10375846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapeutic approaches to the management of rheumatoid arthritis.
    Hughes LB; Moreland LW
    BioDrugs; 2001; 15(6):379-93. PubMed ID: 11520249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching between anti-TNFalpha agents: what is the evidence?
    Combe B
    Joint Bone Spine; 2004 May; 71(3):169-71. PubMed ID: 15182784
    [No Abstract]   [Full Text] [Related]  

  • 40. New and future drug therapies for rheumatoid arthritis.
    Simon LS; Yocum D
    Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():36-42. PubMed ID: 11001378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.